ML14024A442: Difference between revisions

From kanterella
Jump to navigation Jump to search
(Created page by program invented by StriderTol)
(Created page by program invented by StriderTol)
 
Line 15: Line 15:


=Text=
=Text=
{{#Wiki_filter:CENG.a joint venture of Constellation 1619. Energy0 .* -,,eDF NINE MILE POINT NUCLEAR STATION January 7, 2014 U.S. Nuclear Regulatory Commission Washington, DC 20555-0001 ATTENTION:
{{#Wiki_filter:CENG.
a joint venture of Constellation   1619. r*
Energy0         . * -,,eDF NINE MILE POINT NUCLEAR STATION January 7, 2014 U.S. Nuclear Regulatory Commission Washington, DC 20555-0001 ATTENTION:                 Document Control Desk


==SUBJECT:==
==SUBJECT:==
Document Control Desk Nine Mile Point Nuclear Station, Units 1 and 2 Renewed Facility Operating License Nos. DPR-63 and NPF-69 Docket Nos. 50-220 and 50-4 10 Submittal of Report in Accordance with 10 CFR 26.719(c)(1)
Nine Mile Point Nuclear Station, Units 1 and 2 Renewed Facility Operating License Nos. DPR-63 and NPF-69 Docket Nos. 50-220 and 50-4 10 Submittal of Report in Accordance with 10 CFR 26.719(c)(1)


==REFERENCE:==
==REFERENCE:==
(1) Letter from K. J. Clark (NMPNS) to Document Control (NRC), dated November 14, 2013, Nine Mile Point Nuclear Station, Units 1 and 2, Submittal of Report in Accordance with 10 CFR 26.719(c)(1)
In accordance with 10 CFR 26.719(c)(1), Nine Mile Point Nuclear Station, LLC (NMPNS) is submitting the following report regarding unsatisfactory blind performance sample testing:
Description of Incident On November 14, 2013, an amphetamine positive sample was prepared for submittal from NMPNS to a Health and Human Services (HHS)-Laboratory (Quest-Norristown) for blind performance testing, in accordance with 10 CFR 26.168. The sample's manufactured date was July 15, 2013, shipped to NMPNS in October and was noted to expire on January 15, 2014. Results of the sample analyzed by the HI-HIS-laboratory, reported to NMPNS on November 19, 2013, indicated an Invalid test, as well as positive for amphetamines. The HHS-laboratory recognized the sample met the criteria for positive; however, the sample also met the criteria for Invalid, in accordance with 10 CFR 26.161(0(1). This was due to the creatinine of the sample was measured by two (2) different meters at the HI-IS-laboratory which indicated similar readings of approximately 1.0 and 1.3 (which were less than 2 and the specific gravity was greater than 1.0010 but less than 1.0200). The Blind Sample provider (Professional Toxicology) provided documentation that the sample was designed to meet only the positive criteria.
Nine Mile Point Nuclear Station, LLC P.O. Box 63, Lycoming, NY 13093


(1) Letter from K. J. Clark (NMPNS) to Document Control (NRC), dated November 14, 2013, Nine Mile Point Nuclear Station, Units 1 and 2, Submittal of Report in Accordance with 10 CFR 26.719(c)(1)
Document Control Desk January 7, 2014 Page 2 This is very similar to a NMPNS blind sample issue reported to the NRC in Reference (1).
In accordance with 10 CFR 26.719(c)(1), Nine Mile Point Nuclear Station, LLC (NMPNS) is submitting the following report regarding unsatisfactory blind performance sample testing: Description of Incident On November 14, 2013, an amphetamine positive sample was prepared for submittal from NMPNS to a Health and Human Services (HHS)-Laboratory (Quest-Norristown) for blind performance testing, in accordance with 10 CFR 26.168. The sample's manufactured date was July 15, 2013, shipped to NMPNS in October and was noted to expire on January 15, 2014. Results of the sample analyzed by the HI-HIS-laboratory, reported to NMPNS on November 19, 2013, indicated an Invalid test, as well as positive for amphetamines.
Corrective Actions Taken or Planned In addition to contacting the HHS Laboratory and the Blind Sample Provider, NMPNS contacted industry counterparts to determine if any other utility experienced similar issues related to blind sample performance testing. The benchmark revealed that three (3) other utilities experienced the same issue with the same lot number. The blind sample provider did not offer any undisputable reasons for the issues, but did suggest that the issues could have been caused from the bleach wash of their containers or one of the drug-free donor's recent change in diet supplements.
The HHS-laboratory recognized the sample met the criteria for positive; however, the sample also met the criteria for Invalid, in accordance with 10 CFR 26.161(0(1).
Another provider will be procured for 2014.
This was due to the creatinine of the sample was measured by two (2) different meters at the HI-IS-laboratory which indicated similar readings of approximately 1.0 and 1.3 (which were less than 2 and the specific gravity was greater than 1.0010 but less than 1.0200). The Blind Sample provider (Professional Toxicology) provided documentation that the sample was designed to meet only the positive criteria.Nine Mile Point Nuclear Station, LLC P.O. Box 63, Lycoming, NY 13093 Document Control Desk January 7, 2014 Page 2 This is very similar to a NMPNS blind sample issue reported to the NRC in Reference (1).Corrective Actions Taken or Planned In addition to contacting the HHS Laboratory and the Blind Sample Provider, NMPNS contacted industry counterparts to determine if any other utility experienced similar issues related to blind sample performance testing. The benchmark revealed that three (3) other utilities experienced the same issue with the same lot number. The blind sample provider did not offer any undisputable reasons for the issues, but did suggest that the issues could have been caused from the bleach wash of their containers or one of the drug-free donor's recent change in diet supplements.
Should you have any questions regarding the information in this submittal, please contact Everett P.
Another provider will be procured for 2014.Should you have any questions regarding the information in this submittal, please contact Everett P.Perkins, Director -Licensing, at (315) 349-5219.Very truly y Kevin J. Clark Director, Security KJC/MHS cc: NRC Regional Administrator, Region I NRC Project Manager NRC Senior Resident Inspector}}
Perkins, Director - Licensing, at (315) 349-5219.
Very truly y Kevin J. Clark Director, Security KJC/MHS cc:     NRC Regional Administrator, Region I NRC Project Manager NRC Senior Resident Inspector}}

Latest revision as of 09:11, 4 November 2019

Submittal of Report in Accordance with 10 CFR 26.719(c)(1) Regarding Unsatisfactory Blind Performance Sample Testing
ML14024A442
Person / Time
Site: Nine Mile Point  Constellation icon.png
Issue date: 01/07/2014
From: Clark K
Constellation Energy Nuclear Group, EDF Group, Nine Mile Point
To:
Document Control Desk, Office of Nuclear Reactor Regulation
References
Download: ML14024A442 (2)


Text

CENG.

a joint venture of Constellation 1619. r*

Energy0 . * -,,eDF NINE MILE POINT NUCLEAR STATION January 7, 2014 U.S. Nuclear Regulatory Commission Washington, DC 20555-0001 ATTENTION: Document Control Desk

SUBJECT:

Nine Mile Point Nuclear Station, Units 1 and 2 Renewed Facility Operating License Nos. DPR-63 and NPF-69 Docket Nos. 50-220 and 50-4 10 Submittal of Report in Accordance with 10 CFR 26.719(c)(1)

REFERENCE:

(1) Letter from K. J. Clark (NMPNS) to Document Control (NRC), dated November 14, 2013, Nine Mile Point Nuclear Station, Units 1 and 2, Submittal of Report in Accordance with 10 CFR 26.719(c)(1)

In accordance with 10 CFR 26.719(c)(1), Nine Mile Point Nuclear Station, LLC (NMPNS) is submitting the following report regarding unsatisfactory blind performance sample testing:

Description of Incident On November 14, 2013, an amphetamine positive sample was prepared for submittal from NMPNS to a Health and Human Services (HHS)-Laboratory (Quest-Norristown) for blind performance testing, in accordance with 10 CFR 26.168. The sample's manufactured date was July 15, 2013, shipped to NMPNS in October and was noted to expire on January 15, 2014. Results of the sample analyzed by the HI-HIS-laboratory, reported to NMPNS on November 19, 2013, indicated an Invalid test, as well as positive for amphetamines. The HHS-laboratory recognized the sample met the criteria for positive; however, the sample also met the criteria for Invalid, in accordance with 10 CFR 26.161(0(1). This was due to the creatinine of the sample was measured by two (2) different meters at the HI-IS-laboratory which indicated similar readings of approximately 1.0 and 1.3 (which were less than 2 and the specific gravity was greater than 1.0010 but less than 1.0200). The Blind Sample provider (Professional Toxicology) provided documentation that the sample was designed to meet only the positive criteria.

Nine Mile Point Nuclear Station, LLC P.O. Box 63, Lycoming, NY 13093

Document Control Desk January 7, 2014 Page 2 This is very similar to a NMPNS blind sample issue reported to the NRC in Reference (1).

Corrective Actions Taken or Planned In addition to contacting the HHS Laboratory and the Blind Sample Provider, NMPNS contacted industry counterparts to determine if any other utility experienced similar issues related to blind sample performance testing. The benchmark revealed that three (3) other utilities experienced the same issue with the same lot number. The blind sample provider did not offer any undisputable reasons for the issues, but did suggest that the issues could have been caused from the bleach wash of their containers or one of the drug-free donor's recent change in diet supplements.

Another provider will be procured for 2014.

Should you have any questions regarding the information in this submittal, please contact Everett P.

Perkins, Director - Licensing, at (315) 349-5219.

Very truly y Kevin J. Clark Director, Security KJC/MHS cc: NRC Regional Administrator, Region I NRC Project Manager NRC Senior Resident Inspector